Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Phlox Therapeutics logo — RNA's to rescue cardiomyopathies

Phlox Therapeutics

RNA's to rescue cardiomyopathies

Founded 2022 The Netherlands The Netherlands 7 employees Biotechnology, Health and Wellness

General Information

Company Name Phlox Therapeutics
Founded Year 2022
Location The Netherlands The Netherlands +1
Employees 7
Industries Biotechnology, Health and Wellness
Social

Get notified when Phlox Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Phlox Therapeutics

Phlox Therapeutics is a biotechnology startup based in The Netherlands that was founded in 2022. The company's mission is encapsulated in its slogan, "RNA's to rescue cardiomyopathies," which reflects its focus on pioneering gene therapy to alleviate and cure cardiomyopathies. Phlox Therapeutics aims to address the limitations of the current standard of care for patients by leveraging RNA-based strategies to mitigate the negative effects caused by genetic mutations. With an emphasis on embracing new ideas, the company is positioned to make a significant impact in the field of biotechnology. While specific details about Phlox Therapeutics' last investment and the involved investors are not available at the moment, the innovative approach and the potential to address a critical medical need make this startup an intriguing prospect for venture capital firms. As the biotechnology industry continues to garner attention and investment, Phlox Therapeutics' focus on cutting-edge gene therapy positions it favorably for potential future funding and partnerships. This combination of a compelling mission, innovative technology, and a focus on a pressing medical need makes Phlox Therapeutics a company to watch in the biotechnology startup landscape.

Taxonomy: gene therapy, cardiomyopathies, RNA-based strategies, genetic mutations, pharmaceuticals, innovation, medical research, genomics

No funding data available for Phlox Therapeutics yet.

Get notified when Phlox Therapeutics raises funding

Phlox Therapeutics Alternatives & Competitors

Phlox Therapeutics vs
Office of the Secretary of the Navy
Office of the Secretary of the Navy United States

Responsible for acquisition, auditing, financial and information management, legislative affairs, an...

48 employees
Phlox Therapeutics vs
CARMIN
CARMIN Romania

advertising and stuff The quick brown fox jumps over the lazy dog The quick brown fox jumps over t...

14 employees
Phlox Therapeutics vs
The National Bank of Kazakhstan
The National Bank of Kazakhstan Kazakhstan

About the National Bank of the Republic of Kazakhstan The Republic of Kazakhstan has a two-tier ban...

280 employees
Finance, Financial Services

FAQ About Phlox Therapeutics

RNA's to rescue cardiomyopathies
Phlox Therapeutics was founded in 2022.
Phlox Therapeutics is headquartered in The Netherlands.
Phlox Therapeutics operates in the following industries: Biotechnology, Health and Wellness.
Phlox Therapeutics has approximately 7 employees.
Top alternatives and competitors to Phlox Therapeutics include Office of the Secretary of the Navy, CARMIN, The National Bank of Kazakhstan, FUCT™, Medical Edge Communications. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Phlox Therapeutics and Office of the Secretary of the Navy are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Phlox Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes